Pharma Companies Starting To Build Dedicated Digital Marketing/Social Media Staffs
Despite an uncertain regulatory environment and no clear way to link digital marketing and social media activities to revenues, pharmaceutical companies are starting to spend more on promotional activities in the digital realm compared to traditional media (TV/radio/print advertising) and are building dedicated staffs to support these activities.
You may also be interested in...
Social Media Site Could Help FDA Track Adverse Events
FDA-pharma partnership could improve data quality and increase use as industry continues to struggle to incorporate social media into pharmacovigilance.
Pursuit Of R&D Efficiency Continues As Regulatory Options Expand In 2013 – Tufts CSDD
Cutting non-core procedures – such as those supporting exploratory endpoints – from study budgets could save the industry $6 billion a year in drug development costs, the Tufts Center for the Study of Drug Development suggests in its 2013 industry outlook report.
Pharma Promo Spending Mostly Level Despite Challenges
The pharmaceutical industry continues to invest heavily in promotional activities even as many drugs go off patent and new drug launches become less frequent.